Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$3,431,569
+$991,420 QoQ
Shares Held
2,861
+7.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,008
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglas Lane & Associates, LLC holds $414,684,195 across 11 Drug Manufacturers - General names. LLY ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
663,667 | $168,551,507 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
1,556,184 | $89,667,322 | |
| 3 | MRK |
Merck & Co., Inc.
|
552,155 | $70,951,917 | |
| 4 | GSK |
GSK plc
|
946,636 | $49,622,659 | |
| 5 | NVS |
Novartis AG
|
140,152 | $21,964,621 | |
| 6 | AMGN |
Amgen Inc
|
13,032 | $4,719,147 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
2,861 | $3,431,569 | |
| 8 | ABBV |
AbbVie Inc.
|
9,961 | $2,506,586 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,431,569 | 2,861 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $2,440,149 | 2,653 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $2,848,976 | 2,651 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $2,247,798 | 2,946 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $2,326,897 | 2,985 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $2,465,341 | 2,985 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $2,179,356 | 2,823 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $2,254,717 | 2,545 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $2,373,906 | 2,622 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $2,291,092 | 2,945 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $1,904,399 | 3,267 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $1,841,281 | 3,428 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $1,598,752 | 3,409 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $1,171,405 | 3,411 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $1,185,321 | 3,240 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,046,037 | 3,235 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,076,443 | 3,320 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $986,258 | 3,444 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,065,380 | 3,857 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $887,694 | 3,842 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $972,017 | 4,235 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $789,688 | 4,227 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $789,327 | 4,675 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $702,206 | 4,744 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $798,571 | 4,864 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $618,275 | 4,457 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||